1. Home
  2. INUV vs CTSO Comparison

INUV vs CTSO Comparison

Compare INUV & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$2.38

Market Cap

47.2M

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.68

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
CTSO
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.2M
45.7M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
INUV
CTSO
Price
$2.38
$0.68
Analyst Decision
Strong Buy
Buy
Analyst Count
3
2
Target Price
$12.67
$5.38
AVG Volume (30 Days)
370.1K
74.9K
Earning Date
03-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
N/A
N/A
Revenue
$86,209,305.00
$22,503,908.00
Revenue This Year
$12.82
$7.29
Revenue Next Year
$4.23
$8.91
P/E Ratio
N/A
N/A
Revenue Growth
2.88
48.53
52 Week Low
$0.28
$0.60
52 Week High
$6.27
$1.39

Technical Indicators

Market Signals
Indicator
INUV
CTSO
Relative Strength Index (RSI) 47.24 43.57
Support Level $1.67 $0.62
Resistance Level $3.64 $0.74
Average True Range (ATR) 0.22 0.06
MACD -0.03 -0.01
Stochastic Oscillator 6.12 26.60

Price Performance

Historical Comparison
INUV
CTSO

About INUV Inuvo Inc.

Inuvo Inc develops and sells information technology solutions for marketing. It develops technology to deliver content and targeted advertisements over the internet. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: